JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB1930

Anti-Human IgG4 heavy chain antibody [5C7]

Be the first to review this product! Submit a review

|

(3 Publications)

Mouse Monoclonal IGHG4 antibody. Suitable for ELISA and reacts with Human samples. Cited in 3 publications. Immunogen corresponding to Native Full Length Protein corresponding to Human IGHG4.

View Alternative Names

Immunoglobulin heavy constant gamma 4, Ig gamma-4 chain C region, IGHG4

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

5C7

Isotype

IgG1

Carrier free

No

Reacts with

Human

Applications

ELISA

applications

Immunogen

Native Full Length Protein corresponding to Human IGHG4.

P01861

Specificity

Subclass-specific for human IgG4. No allotype restriction. Fc-region specific.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ELISA" : {"fullname" : "ELISA", "shortname":"ELISA"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ELISA-species-checked": "guaranteed", "ELISA-species-dilution-info": "", "ELISA-species-notes": "<p>Specific antibody titer is 1/100,000 by indirect ELISA.</p>" } } }

Product details

Concentration varies from lot to lot and can be provided on request.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Purification notes
Chromatography on protein A SepharosePurified from TCS
Storage buffer
pH: 7.4 Preservative: 0.09% Sodium azide Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Constant region of immunoglobulin (Ig) heavy chains. Igs are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound Igs serve as receptors, which upon binding to a specific antigen trigger the clonal expansion and differentiation of B lymphocytes into Ig-secreting plasma cells. Secreted Igs known as antibodies mediate the effector phase of humoral immunity by blocking the interaction of infectious antigens with cellular receptors (via the antigen-binding region) and eliciting effector mechanisms that lead to pathogen neutralization (via the constant region) (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The antigen-binding region is formed by the variable domain of one heavy chain paired with the variable domain of its associated light chain. Each Ig molecule has two antigen-binding sites with remarkable affinity for a particular antigen due to V-(D)-J rearrangement, somatic hypermutations and affinity maturation of the variable domains upon antigen exposure (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The constant region defines the Ig isotype that perform distinct sets of effector functions. B cells diversify and rearrange their Ig constant regions through class-switch recombination, a process by which the constant region is switched from one Ig isotype to another, namely from IgM and IgD to IgG, IgA and IgE (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The constant region interacts (via the fragment crystallizable, Fc) with the Fc receptors on innate immune cells to mediate humoral effector functions. Ig gamma-4 (IgG4) isotype does not elicit antibody-dependent cellular cytotoxicity (ADDC) or complement-dependent cytotoxicity (CDC). Instead it is likely involved in immune tolerance mechanisms to allergens and parasites either by blocking IgE-antigen complex formation or by directly inhibiting mast cell degranulation through Fc receptor signaling. In the context of tumorigenesis, it may participate in immunosuppressive mechanisms.
See full target information IGHG4

Publications (3)

Recent publications for all applications. Explore the full list and refine your search

Frontiers in oncology 11:731896 PubMed34485161

2021

Transcriptome Profiling Reveals B-Lineage Cells Contribute to the Poor Prognosis and Metastasis of Clear Cell Renal Cell Carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Fafen Yang,Jingjie Zhao,Xiuzhuang Luo,Tong Li,Zechen Wang,Qiuju Wei,Heming Lu,Yiliang Meng,Kai Cai,Liuying Lu,Yushi Lu,Lifen Chen,Suren Rao Sooranna,Linxue Luo,Jian Song,Lingzhang Meng

The Journal of neuroscience : the official journal of the Society for Neuroscience 35:12018-32 PubMed26311781

2015

Myelin Proteolipid Protein Complexes with αv Integrin and AMPA Receptors In Vivo and Regulates AMPA-Dependent Oligodendrocyte Progenitor Cell Migration through the Modulation of Cell-Surface GluR2 Expression.

Applications

Unspecified application

Species

Unspecified reactive species

Danielle E Harlow,Katherine E Saul,Hitoshi Komuro,Wendy B Macklin

BMC infectious diseases 13:608 PubMed24373342

2013

Natural antibody response to Plasmodium falciparum merozoite antigens MSP5, MSP9 and EBA175 is associated to clinical protection in the Brazilian Amazon.

Applications

ELISA

Species

Human

Márcia M Medeiros,Wesley L Fotoran,Rosimeire C dalla Martha,Tony H Katsuragawa,Luiz Hildebrando Pereira da Silva,Gerhard Wunderlich
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com